John G Ullman & Associates Inc. Purchases Shares of 2,060 Xylem Inc. (NYSE:XYL)

John G Ullman & Associates Inc. purchased a new stake in Xylem Inc. (NYSE:XYL) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,060 shares of the industrial products company’s stock, valued at approximately $236,000.

Several other institutional investors have also modified their holdings of XYL. First Trust Advisors LP lifted its position in shares of Xylem by 399.3% during the 1st quarter. First Trust Advisors LP now owns 2,951,349 shares of the industrial products company’s stock worth $251,632,000 after purchasing an additional 2,360,214 shares during the last quarter. Morgan Stanley lifted its position in shares of Xylem by 145.5% during the 4th quarter. Morgan Stanley now owns 3,731,215 shares of the industrial products company’s stock worth $412,561,000 after purchasing an additional 2,211,083 shares during the last quarter. Norges Bank purchased a new stake in Xylem in the fourth quarter valued at $197,762,000. Vanguard Group Inc. lifted its position in Xylem by 7.6% in the first quarter. Vanguard Group Inc. now owns 20,390,911 shares of the industrial products company’s stock valued at $1,738,529,000 after acquiring an additional 1,435,798 shares during the last quarter. Finally, Invesco Ltd. lifted its position in Xylem by 53.6% in the first quarter. Invesco Ltd. now owns 3,828,177 shares of the industrial products company’s stock valued at $326,390,000 after acquiring an additional 1,335,241 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Citigroup boosted their price target on shares of Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Stifel Nicolaus boosted their price target on shares of Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. Royal Bank of Canada boosted their price target on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 7th. Robert W. Baird boosted their price target on shares of Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a research report on Thursday, March 21st. Finally, Raymond James upgraded shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average target price of $138.11.

Xylem Trading Up 0.5 %

Shares of Xylem stock opened at $127.84 on Friday. Xylem Inc. has a 52-week low of $87.59 and a 52-week high of $130.86. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22. The company’s 50-day simple moving average is $127.01 and its 200-day simple moving average is $112.36. The firm has a market cap of $30.99 billion, a price-to-earnings ratio of 47.00, a price-to-earnings-growth ratio of 2.53 and a beta of 1.10.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.03. The business had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The business’s revenue was up 40.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.92 earnings per share. As a group, equities research analysts anticipate that Xylem Inc. will post 4.13 earnings per share for the current year.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were paid a dividend of $0.36 per share. This is an increase from Xylem’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, February 20th. This represents a $1.44 annualized dividend and a dividend yield of 1.13%. Xylem’s dividend payout ratio is presently 52.94%.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.